CME Group (CME)

Outperform Recap: Q2 2026

The Step-Up Holds Against Its Hardest Comp, and the Perpetuals Panic Looks Like a Gift

Outperform Recap: Q1 2026

A Record 36.2 Million-Contract Quarter Across All Six Asset Classes, and a Stock That Shrugged

Hold Recap: Q4 2025

A Fourth Straight Record Year and the Highest Q4 Volume Ever, but the Stock Sits at an All-Time High Into a 2026 Cost Step-Up

Hold Recap: Q3 2025

Volumes Give Back the Record, but a Firmer Rate Per Contract, Record Market Data and Cost Discipline Hold EPS Flat

Hold Recap: Q2 2025

The First 30 Million-Contract Quarter Sets Records Across the Board, but a Flat Tape and a Full Multiple Argue for Patience